Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid

Diagnostic Pathology

Volumn 3, Issue 1, 2008, Pages

  El Demellawy, Dina ^a   Nasr, Ahmed ^b   Alowami, Salem ^c  

^a NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40849102521     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-3-5     Document Type: Article

References (26)

1. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. RV Lloyd LA Erikson MB Casey KY Lam CM Lohse SL Asa JK Chan RA DeLellis HR Harach K Kakudo VA LiVolsi J Rosai TJ Sebo M Sobrinho-Simoes BM Wenig ME Lae, Am J Surg Pathol 2004 28 10 1336 1340 10.1097/01.pas.0000135519. 34847.f6 15371949
2. Observer variation in encapsulated follicular lesions of the thyroid. M Hirokawa JA Carney JR Goellner RA DeLellis CS Heffess R Katoh M Tsujimoto K Kakudo, Am J Surg Pathol 2002 26 1508 1514 10.1097/00000478-200211000-00014 12409728
3. Follicular variant of thyroid papillary carcinoma: a clinicopathological study of six cases. KT Chen J Rosai, Am J Surg Pathol 1977 1 123 130 602974
4. Relationship of the age of patient to natural history and prognosis of carcinoma of the thyroid. GJ Crile J Hazard, Am Surg 1953 138 33 38
5. N-CAM modulates tumour-cell adhesion to matrix by inducing FGFreceptor signalling. U Cavallaro J Niedermayer M Fuxa G Christofori, Nature Cell Biol 2001 3 650 657 10.1038/35083041 11433297
6. The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. U Rutishauser A Acheson AK Hall DM Mann J Sunshine, Science 1988 240 53 57 10.1126/science.3281256 3281256
7. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. M Levrero V De Laurenzi A Costanzo J Gong JY Wang G Melino, J Cell Sci 2000 113 1661 1670 10769197
8. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. JS Reis-Filho FC Schmitt, Adv Anat Pathol 2002 9 280 289 10.1097/00125480-200209000-00002 12195217
9. p63 Expression Profiles in Human Normal and Tumor Tissues. CJ Di Como MJ Urist I Babayan M Drobnjak CV Hedvat J Teruya-Feldstein K Pohar A Hoos C Cordon-Cardo, Clin Cancer Res 2002 8 494 501 11839669
10. p63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression. A Preto JS Reis-Filho S Ricardo P Soares, Pathol Res Pract 2002 198 449 454 10.1078/0344-0338-00281 12234063
11. p63 is a p53 homologue required for limb and epidermal morphogenesis. AA Mills B Zheng XJ Wang H Vogel DR Roop A Bradley, Nature 1999 398 708 713 10.1038/19531 10227293
12. Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19. MR Stone A O'Neill D Catino RJ Bloch, Mol Biol Cell 2005 16 9 4280 93 16000376 10.1091/mbc.E05-02-0112
13. The mouse keratin 19-encoding gene: sequence, structure and chromosomal assignment. M Lussier M Filion JG Compton JH Nadeau L Lapointe A Royal, Gene 1990 95 2 203 213 10.1016/0378-1119(90)90363-V 1701153
14. E-cadherin as an invasion suppressor. W Birchmeier J Hülsken J Behrens, Ciba Found Symp 1995 189 124 36 discussion 136-41, 174-176 7587628
15. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. JKC Chan, Am J Clin Pathol 2002 117 16 18 10.1309/P7QL-16KQ-QLF4-XW0M 11791591
16. Follicular neoplasms of the thyroid: view, biases, and experiences. VA LiVolsi ZW Baloch, Adv Anat Pathol 2004 11 279 287 10.1097/01.pap.0000138143. 34505.02 15505528
17. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. LL Lanier R Testi J Bindl JH Phillips, J Exp Med 1989 169 2233 10.1084/jem.169.6.2233 2471777
18. Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma. GC Owens EA Orr BK Kleinschmidt DeMasters RJ Muschel ME Berens CA Kruse, Cancer Res 1998 58 2020 2028 9581848
19. The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. U Rutishauser A Acheson AK Hall DM Mann J Sunshine, Science 1988 240 53 57 10.1126/science.3281256 3281256
20. Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neuroplastic glia. A Gratsa HK Rooprai JP Rogers KK Martin GJ Pilkengton, Anticancer Res 1997 17 4111 4117 9428343
21. NCAM regulates cell motility. S Prag EA Lepekhin K Kolkova R Hartmann-Petersen A Kawa PS Walmod V Belman HC Gallagher V Berezin E Bock N Pedersen, Journal of Cell Science 2002 115 283 292 11839780
22. Neural cell adhesion molecules (N-CAM) in gastrointestinal neoplasias. P Fogar D Basso C Pasquali M De Paoli C Sperti G Roveroni S Pedrazzoli M Plebani, Anticancer Res 1997 17 1227 1230 9137477
23. Protein and mRNA expression of CD56/NCAM on follicular epithelial cells of the human thyroid. J Zeromski G Dworacki J Jenek Z Niemir E Jezewska R Jenek M Biczysko, Int J Immunopathol Pharmacol 1999 12 23 30 12793959
24. Expression of CD56/N-CAM antigen and some other adhesion molecules in various human endocrine glands. J Zeromski M Lawniczak K Galbas R Jenek P Golusinnski, Folia Histoc Cytobiol 1998 36 119 125
25. Differential xxpression of galectin-1 and galectin-3 in thyroid tumors: potential diagnostic implications. XC Xu AK El-Naggar R Lotan, Am J Pathol 1995 147 815 822 7677193
26. Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with down regulation of VEGF-D production by tumor cells. S Scarpino A Di Napoli F Melotti C Talerico A Cancrini L Ruco, J Pathol 2007 212 4 411 419 10.1002/path.2183 17573672